Long non‑coding RNA SNHG20 promotes ovarian cancer development by targeting microRNA‑338‑3p to regulate MCL1 expression

Wang,Ding; Li,Zhiying; Li,Hui; Lu,Jiao; Qin,Qi

doi:10.3892/ol.2020.12391

Long non‑coding RNA SNHG20 promotes ovarian cancer development by targeting microRNA‑338‑3p to regulate MCL1 expression

Authors:
- Ding Wang
- Zhiying Li
- Hui Li
- Jiao Lu
- Qi Qin
View Affiliations

Affiliations: Department of Gynecology, The Affiliated Renhe Hospital of China Three Gorges University, Yichang, Hubei 443001, P.R. China
Published online on: December 18, 2020 https://doi.org/10.3892/ol.2020.12391
Article Number: 130
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Long non‑coding RNAs (lncRNAs) and microRNAs (miRNAs/miRs) were reported to be associated with the development of ovarian cancer (OC). Increasing evidence demonstrated that lncRNA SNHG20 and miR‑338‑3p were involved in OC. However, the functional mechanism of lncRNA SNHG20 and miR‑338‑3p in OC development remains unknown. The expression of SNHG20, miR‑338‑3p and myeloid cell leukemia 1 (MCL1) was detected by reverse transcription‑quantitative PCR. MTT assay, flow cytometry and transwell migration and invasion assays were used to assess cell proliferation, apoptosis, migration and invasion, respectively. The relative protein expression was detected by western blot analysis. The interaction between miR‑338‑3p and SNHG20 or MCL1 was predicted by starBase v3.0, and subsequently confirmed by dual‑luciferase reporter assay. Besides, mouse xenograft assay was carried out to explore the effect of SNHG20 on tumor growth in vivo. The levels of SNHG20 and MCL1 were upregulated, while miR‑338‑3p level was downregulated in OC tissues and cells. SNHG20 knockdown repressed OC cell proliferation, migration, invasion and epithelial‑mesenchymal transition, and induced apoptosis. Interestingly, SNHG20 targeted miR‑338‑3p to regulate MCL1 expression. miR‑338‑3p depletion or MCL1 overexpression could reverse the effects of SNHG20 knockdown on OC cells. Besides, SNHG20 knockdown impeded tumor growth in vivo. In conclusion, the present study demonstrated that SNHG20 regulates OC development via modulation of the miR‑338‑3p/MCL1 axis, providing the theoretical basis for the treatment of OC.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar
2	Doubeni CA, Doubeni AR and Myers AE: Diagnosis and management of ovarian cancer. Am Fam Physician. 93:937–944. 2016.
3	Xue Y, Ma G, Gu D, Zhu L, Hua Q, Du M, Chu H, Tong N, Chen J, Zhang Z and Wang M: Genome-wide analysis of long noncoding RNA signature in human colorectal cancer. Gene. 556:227–234. 2015. View Article : Google Scholar
4	Xiao J, Lai H, Wei SH, Ye ZS, Gong FS and Chen LC: lncRNA HOTAIR promotes gastric cancer proliferation and metastasis via targeting miR-126 to active CXCR4 and RhoA signaling pathway. Cancer Med. 8:6768–6779. 2019. View Article : Google Scholar
5	Liang H, Su X, Wu Q, Shan H, Lv L, Yu T, Zhao X, Sun J, Yang R, Zhang L, et al: LncRNA promotes ischemic myocardial injury by regulating autophagy through targeting. Autophagy undefined. 1–15. 2019.
6	Li Q, Zhang J, Su DM, Guan LN, Mu WH, Yu M, Ma X and Yang RJ: lncRNA TUG1 modulates proliferation, apoptosis, invasion, and angiogenesis via targeting miR-29b in trophoblast cells. Hum Genomics. 13:502019. View Article : Google Scholar
7	Terashima M, Ishimura A, Wanna-Udom S and Suzuki T: MEG8 long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells. J Biol Chem. 293:18016–18030. 2018. View Article : Google Scholar
8	Lu YM, Wang Y, Liu SQ, Zhou MY and Guo YR: Profile and validation of dysregulated long noncoding RNAs and mRNAs in ovarian cancer. Oncol Rep. 40:2964–2976. 2018.
9	Zhang D, Cao C, Liu L and Wu D: Up-regulation of LncRNA SNHG20 predicts poor prognosis in hepatocellular carcinoma. J Cancer. 7:608–617. 2016. View Article : Google Scholar
10	He S, Zhao Y, Wang X, Deng Y, Wan Z, Yao S and Shen H: Up-regulation of long non-coding RNA SNHG20 promotes ovarian cancer progression via Wnt/β-catenin signaling. Biosci Rep. 38:BSR201706812018. View Article : Google Scholar
11	Trionfini P and Benigni A: MicroRNAs as master regulators of glomerular function in health and disease. J Am Soc Nephrol. 28:1686–1696. 2017. View Article : Google Scholar
12	Wang Y, Kim S and Kim IM: Regulation of metastasis by microRNAs in ovarian cancer. Front Oncol. 4:1432014. View Article : Google Scholar
13	Sun J, Qiao Y, Song T and Wang H: MiR-495 suppresses cell proliferation by directly targeting HMGA2 in lung cancer. Mol Med Rep. 19:1463–1470. 2019.
14	Liu C, Cai L and Li H: miR185 regulates the growth of osteosarcoma cells via targeting Hexokinase 2. Mol Med Rep. 20:2774–2782. 2019.
15	Luo Y, Hao T, Zhang J, Zhang M, Sun P and Wu L: MicroRNA-592 suppresses the malignant phenotypes of thyroid cancer by regulating lncRNA NEAT1 and downregulating NOVA1. Int J Mol Med. 44:1172–1182. 2019.
16	Wang C, Zhang W, Xing S, Wang Z, Wang J and Qu J: MiR-342-3p inhibits cell migration and invasion through suppressing forkhead box protein Q1 in ovarian carcinoma. Anticancer Drugs. 30:917–924. 2019. View Article : Google Scholar
17	Zhang Y, Shi B, Chen J, Hu L and Zhao C: MiR-338-3p targets pyruvate kinase M2 and affects cell proliferation and metabolism of ovarian cancer. Am J Transl Res. 8:3266–3273. 2016.
18	Liu X, Wen J, Wang H and Wang Y: Long non-coding RNA LINC00460 promotes epithelial ovarian cancer progression by regulating microRNA-338-3p. Biomed Pharmacother. 108:1022–1028. 2018. View Article : Google Scholar
19	Yip KW and Reed JC: Bcl-2 family proteins and cancer. Oncogene. 27:6398–6406. 2008. View Article : Google Scholar
20	Zhang S, Zhang M, Jing Y, Yin X, Ma P, Zhang Z, Wang X, Di W and Zhuang G: Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors. Nat Commun. 9:2152018. View Article : Google Scholar
21	Su J, Ruan S, Dai S, Mi J, Chen W and Jiang S: NF1 regulates apoptosis in ovarian cancer cells by targeting MCL1 via miR-142-5p. Pharmacogenomics. 20:155–165. 2019. View Article : Google Scholar
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
23	Sun Q, Li Q and Xie F: LncRNA-MALAT1 regulates proliferation and apoptosis of ovarian cancer cells by targeting miR-503-5p. Onco Targets Ther. 12:6297–6307. 2019. View Article : Google Scholar
24	Wang Y, Huang Y, Liu H, Su D, Luo F and Zhou F: Long noncoding RNA CDKN2B-AS1 interacts with miR-411-3p to regulate ovarian cancer in vitro and in vivo through HIF-1a/VEGF/P38 pathway. Biochem Biophys Res Commun. 514:44–50. 2019. View Article : Google Scholar
25	You Q, Shi HY, Gong CF, Tian XY and Li S: Long non-coding RNA DLX6-AS1 acts as an oncogene by targeting miR-613 in ovarian cancer. Eur Rev Med Pharmacol Sci. 23:6429–6435. 2019.
26	Wu X, Xiao Y, Zhou Y, Zhou Z and Yan W: lncRNA SNHG20 promotes prostate cancer migration and invasion via targeting the miR-6516-5p/SCGB2A1 axis. Am J Transl Res. 11:5162–5169. 2019.
27	Liu J, Cheng LG and Li HG: LncRNA SNHG20 promoted the proliferation of glioma cells via sponging miR-4486 to regulate the MDM2-p53 pathway. Eur Rev Med Pharmacol Sci. 23:5323–5331. 2019.
28	Gao XF, He HQ, Zhu XB, Xie SL and Cao Y: LncRNA SNHG20 promotes tumorigenesis and cancer stemness in glioblastoma via activating PI3K/Akt/mTOR signaling pathway. Neoplasma. 66:532–542. 2019. View Article : Google Scholar
29	Sun C, Sun Y and Zhang E: Long non-coding RNA SNHG20 promotes nasopharyngeal carcinoma cell migration and invasion by upregulating TGF-β1. Exp Ther Med. 16:4967–4974. 2018.
30	Zhao W, Ma X, Liu L, Chen Q, Liu Z, Zhang Z, Ma S, Wang Z, Li H, Wang Z and Wu J: SNHG20: A vital lncRNA in multiple human cancers. J Cell Physiol. Jan 15–2019.(Epub ahead of print).
31	Wang D, Dai J, Hou S and Qian Y: LncRNA SNHG20 predicts a poor prognosis and promotes cell progression in epithelial ovarian cancer. Biosci Rep. 39:BSR201821862019. View Article : Google Scholar
32	Chen Z, Chen X, Chen P, Yu S, Nie F, Lu B, Zhang T, Zhou Y, Chen Q, Wei C, et al: Long non-coding RNA SNHG20 promotes non-small cell lung cancer cell proliferation and migration by epigenetically silencing of P21 expression. Cell Death Dis. 8:e30922017. View Article : Google Scholar
33	Liu J, Liu L, Wan JX and Song Y: Long noncoding RNA SNHG20 promotes gastric cancer progression by inhibiting p21 expression and regulating the GSK-3β/β-catenin signaling pathway. Oncotarget. 8:80700–80708. 2017. View Article : Google Scholar
34	Guo LP, Zhang ZJ, Li RT, Li HY and Cui YQ: Influences of LncRNA SNHG20 on proliferation and apoptosis of glioma cells through regulating the PTEN/PI3K/AKT signaling pathway. Eur Rev Med Pharmacol Sci. 23:253–261. 2019.
35	Guo H, Yang S, Li S, Yan M, Li L and Zhang H: LncRNA SNHG20 promotes cell proliferation and invasion via miR-140-5p-ADAM10 axis in cervical cancer. Biomed Pharmacother. 102:749–757. 2018. View Article : Google Scholar
36	Sun F, Liang W, Tang K, Hong M and Qian J: Profiling the lncRNA-miRNA-mRNA ceRNA network to reveal potential crosstalk between inflammatory bowel disease and colorectal cancer. PeerJ. 7:e74512019. View Article : Google Scholar
37	Wang X, Lan Z, He J, Lai Q, Yao X, Li Q, Liu Y, Lai H, Gu C, Yan Q, et al: LncRNA SNHG6 promotes chemoresistance through ULK1-induced autophagy by sponging miR-26a-5p in colorectal cancer cells. Cancer Cell Int. 19:2342019. View Article : Google Scholar
38	Liu X, Zhu Q, Guo Y, Xiao Z, Hu L and Xu Q: LncRNA LINC00689 promotes the growth, metastasis and glycolysis of glioma cells by targeting miR-338-3p/PKM2 axis. Biomed Pharmacother. 117:1090692019. View Article : Google Scholar
39	Li M, Bian Z, Jin G, Zhang J, Yao S, Feng Y, Wang X, Yin Y, Fei B, You Q and Huang Z: LncRNA-SNHG15 enhances cell proliferation in colorectal cancer by inhibiting miR-338-3p. Cancer Med. 8:2404–2413. 2019. View Article : Google Scholar
40	Zhang R, Shi H, Ren F, Liu Z, Ji P, Zhang W and Wang W: Down-regulation of miR-338-3p and Up-regulation of MACC1 indicated poor prognosis of epithelial ovarian cancer patients. J Cancer. 10:1385–1392. 2019. View Article : Google Scholar
41	Huang Y, Luo H, Li F, Yang Y, Ou G, Ye X and Li N: LINC00152 down-regulated miR-193a-3p to enhance MCL1 expression and promote gastric cancer cells proliferation. Biosci Rep. 38:BSR201716072018. View Article : Google Scholar
42	Suzuki J, Nakajima W, Suzuki H, Asano Y and Tanaka N: Chaperone-mediated autophagy promotes lung cancer cell survival through selective stabilization of the pro-survival protein, MCL1. Biochem Biophys Res Commun. 482:1334–1340. 2017. View Article : Google Scholar
43	Zhou C, Li G, Zhou J, Han N, Liu Z and Yin J: miR-107 activates ATR/Chk1 pathway and suppress cervical cancer invasion by targeting MCL1. PLoS One. 9:e1118602014. View Article : Google Scholar
44	Xu W, Li Z, Zhu X, Xu R and Xu Y: miR-29 family inhibits resistance to methotrexate and promotes cell apoptosis by targeting COL3A1 and MCL1 in osteosarcoma. Med Sci Monit. 24:8812–8821. 2018. View Article : Google Scholar